• E-mail
  • Save
11 Stories on Liver Cancer
Search this topic

Time.com: Liver Disease Plagues Obese Kids

In a new and disturbing twist on the obesity epidemic, some overweight teenagers have severe liver damage caused by too much body fat, and a handful have needed liver transplants

FSB: A tiny cure for cancer?

Both aggressive and hard to treat, liver cancer kills more than 650,000 a year worldwide. The American Cancer Society pegs the overall survival rate at less than 10%. Enter Aura Biosciences, a student startup that has developed an ingenious new means of delivering cancer-killing drugs to liver (and other) tumors.

Time.com: Study: Liver Cancer Breakthrough

For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year

CNNMoney: Stocks knocked back

Stocks slipped Monday as falling oil prices and a rash of corporate deals failed to rally investors concerned about reports on housing and testimony from Federal Reserve Chairman Ben Bernanke due later this week.

CNNMoney: Oil slide no help for investors

Stocks tumbled Monday afternoon, as a rash of corporate deals and a big selloff in oil prices failed to inspire investors ahead of key reports on housing and retail and testimony from Fed chief Ben Bernanke - all due later this week.

Doubt, humor, hope, motherhood

The late Marjorie Williams was honest about others, and with herself.

Fortune: How disease evolves

BACK WHEN HE WAS A GRAD STUDENT IN 1977, Paul Ewald came down with an intestinal bug. He'd been doing research at the University of Washington at Seattle on the social behavior of sparrows. But the...

Study: Cancer no longer rare in poorer countries

Poor countries have cancer rates much closer to those of rich nations, reversing a long-held belief among medical researchers, a study released Thursday reports.

FSB: Drug Money

Blue-Chip Investors are rallying behind tiny Eximias Pharmaceutical Corp., which has spent four years developing a new chemotherapy drug for liver cancer (see "The Miracle Hunter," in February's FS...

FSB: The Miracle Hunter How Elizabeth Corsi turned a drug nobody wanted into a company that could soon gross $500 million--and prolon

For Ernest Lynton, the diagnosis was a death sentence. He had cancer of the pancreas, a disease so lethal that he would be lucky to live six months. Surgery had failed--the tumor was too large--and...

Advertisement
Quick Job Search :
keyword(s):
enter city: